MMA Embolization for Refractory Chronic Migraine
NCT: NCT06735833 · RECRUITING
NCT IDNCT06735833
StatusRECRUITING
Start Date2025-04-23
Completion2029-07-31
Brief Summary
This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.
Frequently Asked Questions
What is MMA Embolization for Refractory Chronic Migraine?
MMA Embolization for Refractory Chronic Migraine is a clinical trial registered under NCT06735833. Current status: RECRUITING.
What is the status of NCT06735833?
The current status of NCT06735833 (MMA Embolization for Refractory Chronic Migraine) is: RECRUITING.
When did MMA Embolization for Refractory Chronic Migraine start?
MMA Embolization for Refractory Chronic Migraine started on 2025-04-23.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.